Bruker Reports Third Quarter 2023 Financial Results : vimars

Q3 2023 revenues of $742.8 million, up 16.3% year-over-year ; organic revenue up 10.9% yoy



Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy



Bruker increases FY 2023 revenue guidance to...

Related Keywords

Taiwan , Israel , Russia , United States , Ukraine , China , Frankh Laukien , Bruker Biospin , Bruker Nano , Asia Pacific , Exchange Commission , Securities Exchange , Bruker Corporation , Bruker Corporation Nasdaq , Bruker Energy Supercon Technologies , Phenomex Inc , Scientific Instruments , Supercon Technologies , Nine Months , Cellular Analysis , Bruker Cellular Analysis , Investor Relations , Securities Act , Securities Exchange Act , Purchase Agreement , Before Tax , Per Share , Cash Flow , Invested Capital , Tax Provision , Revenue Growth , Organic Revenue , Organic Revenue Growth , Bruker Scientific Instruments , Nano Segments , Markets ,